Trials / Completed
CompletedNCT00560209
Study of ONO-1101 in Patients Scheduled for Coronary Angiography
Study of ONO-1101 in Patients Scheduled for Coronary Angiography, a Double-Blind, Randomized,Placebo-Controlled, Parallel Group, Multi-Center Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 183 (actual)
- Sponsor
- Ono Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of ONO-1101 in patients scheduled for coronary angiography, in a double-blind, randomized, placebo-controlled, parallel group, multi-center study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ONO-1101 | placebo for 1 minute IV |
| DRUG | ONO-1101 | 0.06 mg/kg for 1 minute IV |
| DRUG | ONO-1101 | 0.125 mg/kg for 1 minute IV |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2008-11-01
- First posted
- 2007-11-19
- Last updated
- 2012-06-13
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT00560209. Inclusion in this directory is not an endorsement.